Scientists and studies have long found that people of all ages who are regularly touched tend to be less anxious, recover ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Discover the power of music therapy for dementia. Learn how music can reduce distress and improve well-being in institutional ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

Why the once-stigmatized treatment is back for women under 60.